Mike Hoerres is a seasoned strategic advisor and CEO with extensive experience in driving growth in life science tools, diagnostics, and health technology. Currently serving as Chief Executive Officer at AEGEA Biotechnologies since 2025, they lead initiatives focused on advancing precision medicine through innovative nucleic acid technologies. Previously, Mike held leadership roles including CEO of Cernostics, where they developed TissueCypher, a groundbreaking diagnostic test for esophageal cancer. Their past experience includes key positions at companies such as Incyte Genomics, Affymetrix, and Geisinger Health System, contributing to market development and strategic partnerships in the health sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices